FDA Approves New Injection Brolucizumab (Beovu ) for Wet AMD FDA Approves New Injection Brolucizumab (Beovu ) for Wet AMD

The US Food and Drug Administration approved brolucizumab (Beovu, Novartis) injection for wet age-related macular degeneration (AMD).FDA Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Ophthalmology News Alert Source Type: news